Target DDR Pathways in GBM, From Mechanistic Insights to Advances in the Clinic

Time: 2:45 pm
day: Day Two


  •  Update on DDR pathways as they pertain to GBM
  • Overview on the latest DDR inhibitors, molecular biomarkers, and their
    use in clinical trials
  • Examine new trials targeting GBM with DDR inhibitors and DNA
    damaging agents